Navigation Links
Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine Comes to the App Store
Date:8/3/2011

PHILADELPHIA, August 3, 2011 /PRNewswire/ --


- Content From the Widely-respected Cardiology Reference Book's Forthcoming Ninth Edition Now Available to Users on iPad, iPhone and iPod Touch


Elsevier, the leading provider of scientific, technical and medical information products and services, announced its Braunwald's Heart Disease Practice Guides App for iPad, iPhone and iPod Touch is now available on the App Store. The app includes content from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, Ninth Edition, and provides the most up-to-date, evidence-based cardiology clinical practice guidelines from the American College of Cardiology (ACC) and the American Heart Association (AHA).

Braunwald's Heart Disease Practice Guidelines App provides access to the most useful, clinically actionable and evidence-based cardiology clinical practice guidelines today. The joint cardiovascular practice guidelines of the ACC and the AHA have become important documents for guiding cardiology practice and establishing benchmarks for quality of care. In each edition of Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, the market-leading global clinical textbook of cardiology, authors and editors summarize all the latest ACC/AHA practice guidelines and transform them into clinically actionable points presented in an easily accessible, bulleted format. For the first time the guidelines have been streamlined for mobile presentation and are available for download by cardiologists and all related healthcare professionals who want mobile access to this clinically actionable information in a high-yield, bulleted format.

"We wanted to provide cardiologists and healthcare professionals the ability to have the most up-to-date information available right at their fingertips," said Dr. Eugene Braunwald, founding editor and online editor of Braunwald's Heart Disease.  "This app will give clinicians and professionals anytime, anywhere access to this important information so they can continue to provide the best quality of care possible for their patients."

Braunwald's Heart Disease Practice Guidelines App has several features, including:

  • Content from the brand-new, ninth edition of Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine;
  • Content and cases based on the latest published evidence;
  • Clinically actionable points presented in an easily-digested, bulleted format;
  • Easy navigation, searching and browsing options.


Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, Ninth Edition features definitive, state-of-the-art answers covering every aspect of contemporary cardiology.  Edited by Drs. Robert Bonow, Douglas Mann, Douglas Zipes, and Peter Libby, the reference applies the most recent knowledge in molecular biology and genetics, imaging, pharmacology, interventional cardiology, electrophysiology, and much more. Additionally, the new edition features online content, including new dynamic cardiac imaging videos, heart sound recordings, and podcasts.

The Braunwald's Heart Disease Practice Guidelines App is available for $24.99 from the App Store on iPad, iPhone and iPod touch, or at http://www.itunes.com/appstore .

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).


Media contact
Tom Reller
Vice President Global Corporate Relations, Elsevier
+1-212-462-1912
t.reller@elsevier.com




'/>"/>
SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare to Report Financial Results for Second Quarter of 2011
2. German Patient Surpasses 5 Years of Support on DuraHeart™ Left Ventricular Assist Device
3. TandemHeart Approved for Expanded Reimbursement
4. Cardiac Science Gains Japanese Regulatory Approval for Powerheart AED
5. CardioFocus HeartLight™ Endoscopic Ablation System Enables Treatment of Atrial Fibrillation: Live Case and Abstract Presented at EHRA EUROPACE 2011
6. New Study Shows Viability of Heart Pumps for Older Heart-Failure Patients
7. Analysis Finds BYETTA® Associated with Lower Likelihood of Heart Failure Compared with Other Diabetes Therapies: Results Presented at ADA 2011
8. Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation
9. CardioFocus HeartLight™ Endoscopic Ablation System to be Featured at EHRA EUROPACE 2011
10. Franciscan St. Francis Heart Center Surgeon Pioneers Use of Heart Valve Repair Ring
11. HeartWare to Present at the Wells Fargo 2011 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
(Date:10/7/2017)... Texas , Oct. 6, 2017   Provista, ... with more than $100 billion in purchasing power, today ... news and information. The Newsroom is the ... and industry trends, infographics, expert bios, news releases, slideshows ... having access to a wealth of resources at their ...
(Date:10/2/2017)... Oct. 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... Software and Consulting, LLC , and named its founder ... based in Tennessee , will operate ... expands EnvoyHealth,s service offerings for health care partners to ... "In an interoperable world, technology ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris F. ... AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking place ... the field of medical informatics, this prestigious award is presented to an individual whose ...
Breaking Medicine News(10 mins):